About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials in Maryland | 690 Studies

Clinical Trials Prostate CancerMaryland

Prostate Cancer Clinical Trials in Maryland

Find 690 clinical trials for prostate cancer near Maryland. Connect with research centers in your area.

All Prostate Cancer trials nationwide All trials in Maryland

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 421-440 of 690 trials

CompletedEfficacy and Safety of Leuprolide Acetate 22.5 mg Depot in Treatment of Prostate CancerSome patients with prostate cancer benefit from androgen deprivation therapy which reduces levels of testosterone.NCT01415960·San Diego, California and 24 others CompletedOpen Label Study of Sipuleucel-T in Metastatic Prostate CancerThis is a Multicenter, Open Label, Phase 2 Study of Sipuleucel-T in Men with Metastatic Castrate Resistant Prostate Cancer (CRPC).NCT00901342·Washington D.C., District of Columbia and 17 others

Prostate Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedF-18 Sodium Fluoride in Prostate CancerBackground: \- Sodium fluoride (NaF) is a common compound that is found in various foods and can be used to increase bone strength.NCT01240551·Bethesda, Maryland

CompletedAn Efficacy and Safety Study of Abiraterone Acetate and Prednisone in Participants With Prostate Cancer Who Failed Androgen Deprivation and Docetaxel-Based ChemotherapyThe purpose of this study is to evaluate the efficacy and safety of abiraterone acetate in participants with advanced prostate cancer (a disease in which cells in the prostate…NCT00485303·Los Angeles, California and 13 others

CompletedSequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate CancerThe main purpose of this study was to determine whether ADT started before or after sipuleucel-T led to a better immune system response.NCT01431391·Homewood, Alabama and 13 others

CompletedHighly Conformal, Hypofractionated, Focally Dose Escalated Post-Prostatectomy RadiotherapyBackground: Sometimes prostate cancer comes back after a person's prostate is removed. In this case, radiation is a common treatment.NCT03388619·Bethesda, Maryland

CompletedCabozantinib Plus Docetaxel and Prednisone for Advanced Prostate CancerBackground: \- Cabozantinib is a drug that slows the growth of blood vessels that feed tumors. It is approved for medullary thyroid cancer.NCT01683994·Bethesda, Maryland

CompletedPhase II Sunitinib Prog Met AIPCThe purpose of this research study is to find out what effects (good and bad) Sutent has on you and your prostate cancer.NCT00599313·Phoenix, Arizona and 44 others

CompletedStandard Dose Versus High Dose and Versus Extended Standard Dose Radium-223 Dichloride in Castration-resistant Prostate Cancer Metastatic to the BoneThis study will assess different doses and regimens of radium-223 dichloride on the incidence of symptomatic skeletal events.NCT02023697·Scottsdale, Arizona and 67 others

UnknownProstate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising Prostate Specific Antigen (PSA) After Surgery for Prostate CancerRATIONALE: Radiation therapy uses high-energy x-rays to kill tumor cells. Androgens can cause the growth of prostate cancer cells.NCT00567580·Birmingham, Alabama and 459 others

CompletedAblation of Prostate Tissue Utilizing Sterile Water Vapor in Patients With Intermediate Risk Localized Prostate CancerThe purpose of this research study is to collect information on a new treatment of prostate tissue participants with intermediate risk prostate cancer using a medical device…NCT04087980·Baltimore, Maryland and 4 others

CompletedA Study to Determine Frequency of DNA-repair Defects in Men With Metastatic Prostate CancerThe purpose of this study is to evaluate the prevalence of 4 or more DNA-repair gene defects in a population of men with metastatic Prostate Cancer (PC) and to use the reported…NCT03871816·Homewood, Alabama and 337 others

Active not recruitingA Study of Apalutamide (ARN-509) in Men With Non-Metastatic Castration-Resistant Prostate CancerThe purpose of this study is to evaluate the efficacy and safety of apalutamide in adult men with high-risk non-metastatic castration-resistant prostate cancer.NCT01946204·Birmingham, Alabama and 378 others

CompletedKetoconazole, Hydrocortisone and Dutasteride in Asymptomatic Hormone Refractory Prostate CancerThe combination of ketaconazole and hydrocortisone is commonly used for the treatment of prostate cancer.NCT00673127·Baltimore, Maryland and 6 others

CompletedA Chemoprevention Study of an Investigational Drug in Men With High Grade Prostate Intraepithelial Neoplasia (PIN)If you are a male 30 years of age or older and have a positive diagnosis of high grade (II or III) prostate Intraepithelial Neoplasia (PIN) or have had an abnormal/suspicious…NCT00028353·Huntsville, Alabama and 24 others

RecruitingPhysician- and Patient-based Barriers to NGS TestingThe goal of this study is to improve next-generation sequencing (NGS) testing rates at Johns Hopkins in patients with metastatic prostate cancer.NCT07209176·Baltimore, Maryland

RecruitingThe COSMYC Trial (COmbined Suppression of MYC)This research is being done to determine if receiving the combination of testosterone and ZEN-3694 followed by the combination of enzalutamide plus ZEN-3694 will decrease the size…NCT06922318·Baltimore, Maryland

Active not recruitingStudy of TGF-β Receptor Inhibitor Galunisertib (LY2157299) and Enzalutamide in Metastatic Castration-resistant Prostate CancerThe primary objective of this study is to compare the progression free survival (PFS) of patients with metastatic castration-resistant prostate cancer treated with enzalutamide in…NCT02452008·Washington D.C., District of Columbia and 3 others

CompletedPI3Kbeta Inhibitor AZD8186 and Docetaxel in Treating Patients Advanced Solid Tumors With PTEN or PIK3CB Mutations That Are Metastatic or Cannot Be Removed by SurgeryThis phase I trial studies the side effects and best dose of PI3Kbeta inhibitor AZD8186 when given together with docetaxel in treating patients with solid tumors with PTEN or…NCT03218826·Aurora, Colorado and 7 others

CompletedDocetaxel, Thalidomide, Prednisone, and Bevacizumab to Treat Metastatic Prostate CancerThis is a Phase II study of docetaxel, bevacizumab, prednisone and thalidomide in patients with androgen independent metastatic prostate cancer who are previously untreated with…NCT00089609·Bethesda, Maryland

PreviousPage 22 of 35Next

Other Conditions in Maryland

Breast Cancer Lung Cancer Colorectal Cancer Melanoma Leukemia Lymphoma